{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:09:11Z","timestamp":1774076951125,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270866"],"award-info":[{"award-number":["82270866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.diabres.2024.111882","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:37:25Z","timestamp":1727883445000},"page":"111882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hypoglycemic drugs, circulating inflammatory proteins, and gallbladder diseases: A mediation mendelian randomization study"],"prefix":"10.1016","volume":"217","author":[{"given":"Zi-Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2507-9192","authenticated-orcid":false,"given":"Jian-Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111882_b0005","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones [J]","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.diabres.2024.111882_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer [J]","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut and Liver"},{"issue":"4","key":"10.1016\/j.diabres.2024.111882_b0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.32183","article-title":"Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study [J]","volume":"75","author":"Chen","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.diabres.2024.111882_b0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc22-1385","article-title":"Gastrointestinal consequences of type 2 diabetes mellitus and impaired glycemic homeostasis: a mendelian randomization study [J]","volume":"46","author":"Chen","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2024.111882_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/dci19-0066","article-title":"2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [J]","volume":"43","author":"Buse","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111882_b0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fphar.2017.00765","article-title":"Metformin use correlates with reduced risk of gallstones in diabetic patients: A 12-year follow-up study [J]","volume":"8","author":"Liao","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2024.111882_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068882","article-title":"Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials [J]","author":"He","year":"2022","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.diabres.2024.111882_b0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials [J]","volume":"182","author":"He","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.diabres.2024.111882_b0045","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/jgh.14265","article-title":"Association of circulating inflammation proteins and gallstone disease [J]","volume":"33","author":"Liu","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2024.111882_b0050","first-page":"52","article-title":"Inflammatory markers of gallstones disease in menopausal women [J]","volume":"208\u2013209","author":"Shengelia","year":"2012","journal-title":"Georgian Med News"},{"key":"10.1016\/j.diabres.2024.111882_b0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2016.05.003","article-title":"Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies [J]","volume":"83","author":"Koshiol","year":"2016","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.diabres.2024.111882_b0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/bjd\/ljad305","article-title":"Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa [J]","volume":"189","author":"Petrasca","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.diabres.2024.111882_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control [J]","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.diabres.2024.111882_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109080","article-title":"The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents [J]","volume":"111","author":"Theofilis","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.diabres.2024.111882_b0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2018.03.039","article-title":"Linagliptin attenuates chronic post-ischemia pain: Possible anti-inflammatory and anti-oxidant mechanisms [J]","volume":"828","author":"Hewedy","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111882_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?* [J]","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111882_b0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations [J]","volume":"33","author":"Smith","year":"2004","journal-title":"Int J Epidemiol"},{"issue":"R1","key":"10.1016\/j.diabres.2024.111882_b0090","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies [J]","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0095","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ije\/dyw127","article-title":"Commentary: Two-sample mendelian randomization: opportunities and challenges [J]","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.diabres.2024.111882_b0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data [J]","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"11","key":"10.1016\/j.diabres.2024.111882_b0105","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/dc22-0323","article-title":"SGLT2 inhibition, choline metabolites, and cardiometabolic diseases: a mediation mendelian randomization study [J]","volume":"45","author":"Xu","year":"2022","journal-title":"Diabetes Care"},{"issue":"D1","key":"10.1016\/j.diabres.2024.111882_b0110","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024 [J]","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.diabres.2024.111882_b0115","unstructured":"The GTEx Consortium atlas of genetic regulatory effects across human tissues [J]. Science (New York, NY), 2020; 369(6509): 1318-30."},{"issue":"11","key":"10.1016\/j.diabres.2024.111882_b0120","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/s41590-023-01635-6","article-title":"Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets [J]","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111882_b0125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes [J]","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.diabres.2024.111882_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00518-22","article-title":"FXR signaling-mediated bile acid metabolism is critical for alleviation of cholesterol gallstones by lactobacillus strains [J]","volume":"10","author":"Ye","year":"2022","journal-title":"Microbiology spectrum"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0135","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice [J]","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111882_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2018.06.002","article-title":"Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl\/6 mice [J]","volume":"833","author":"Dorvash","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111882_b0145","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2337\/dc19-0415","article-title":"Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial [J]","volume":"42","author":"Nauck","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2024.111882_b0150","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2018-01008","article-title":"New avenues in the regulation of gallbladder motility-implications for the use of glucagon-like peptide-derived drugs [J]","volume":"104","author":"Gether","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.diabres.2024.111882_b0155","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/00365521.2018.1530297","article-title":"Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs [J]","volume":"53","author":"Rehfeld","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111882_b0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2016.1531","article-title":"Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus [J]","volume":"176","author":"Faillie","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.diabres.2024.111882_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide [J]","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111882_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5603\/FM.2015.0011","article-title":"Analysis of immunohistochemical expression of proinflammatory cytokines (IL-1\u03b1, IL-6, and TNF-\u03b1) in gallbladder mucosa: comparative study in acute and chronic calculous cholecystitis [J]","volume":"74","author":"Kasprzak","year":"2015","journal-title":"Folia Morphol"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jphs.2014.12.007","article-title":"Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats [J]","volume":"127","author":"Liu","year":"2015","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration [J]","volume":"171","author":"Wang","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.diabres.2024.111882_b0185","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00463.2010","article-title":"Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice [J]","volume":"300","author":"Dobrian","year":"2011","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jgh.12435","article-title":"Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer [J]","volume":"29","author":"Koh","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2024.111882_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112541","article-title":"Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study [J]","volume":"138","author":"El-Haggar","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111882_b0200","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/eji.1830231046","article-title":"Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells [J]","volume":"23","author":"Sironi","year":"1993","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.diabres.2024.111882_b0205","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages [J]","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"7","key":"10.1016\/j.diabres.2024.111882_b0210","first-page":"546","article-title":"Cholesterol crystals activate NLRP3 inflammasomes and promote gallstone formation by increasing mucin secretion [J]","volume":"97","author":"Lei","year":"2022","journal-title":"BiotechHistochem: Official Publication of the Biological Stain Commission"},{"issue":"2","key":"10.1016\/j.diabres.2024.111882_b0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1091-255X(00)80055-4","article-title":"Inflammatory cytokines alter human gallbladder epithelial cell absorption\/secretion [J]","volume":"4","author":"Rege","year":"2000","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.diabres.2024.111882_b0220","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.immuni.2014.03.011","article-title":"Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function [J]","volume":"40","author":"Shouval","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.diabres.2024.111882_b0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis [J]","volume":"75","author":"K\u00fcHN","year":"1993","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.diabres.2024.111882_b0230","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","article-title":"Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility [J]","volume":"40","author":"Franke","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.diabres.2024.111882_b0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/gutjnl-2019-318264","article-title":"Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling [J]","volume":"69","author":"Koelink","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.diabres.2024.111882_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040697","article-title":"The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases [J]","volume":"9","author":"Baldelli","year":"2021","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.diabres.2024.111882_b0245","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1053\/j.gastro.2007.07.005","article-title":"T-cell function is critical for murine cholesterol gallstone formation [J]","volume":"133","author":"Maurer","year":"2007","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.diabres.2024.111882_b0250","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1080\/15384101.2015.1060382","article-title":"Direct conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAs [J]","volume":"14","author":"Xu","year":"2015","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"9","key":"10.1016\/j.diabres.2024.111882_b0255","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1096\/fj.201700115R","article-title":"Early life allergen-induced mucus overproduction requires augmented neural stimulation of pulmonary neuroendocrine cell secretion [J]","volume":"31","author":"Barrios","year":"2017","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.diabres.2024.111882_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060676","article-title":"Role of secretory mucins in the occurrence and development of cholelithiasis [J]","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.diabres.2024.111882_b0265","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/14728222.2020.1846720","article-title":"Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? [J]","volume":"24","author":"de Miranda","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.diabres.2024.111882_b0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.vh.2016.10.010","article-title":"The role of neurotrophins in inflammation and allergy [J]","volume":"104","author":"Manti","year":"2017","journal-title":"Vitam Horm"},{"issue":"1","key":"10.1016\/j.diabres.2024.111882_b0275","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41398-023-02459-6","article-title":"Depression and 24 gastrointestinal diseases: a Mendelian randomization study [J]","volume":"13","author":"Ruan","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.diabres.2024.111882_b0280","first-page":"173","article-title":"Equivalence of the mediation, confounding and suppression effect [J]","volume":"1","author":"Mackinnon","year":"2000","journal-title":"PreventionScience: The Official Journal of the Society for Prevention Research"},{"issue":"3","key":"10.1016\/j.diabres.2024.111882_b0285","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models [J]","volume":"40","author":"Preacher","year":"2008","journal-title":"Behav Res Methods"},{"issue":"6","key":"10.1016\/j.diabres.2024.111882_b0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations [J]","volume":"51","author":"Baron","year":"1986","journal-title":"J Pers Soc Psychol"},{"issue":"7","key":"10.1016\/j.diabres.2024.111882_b0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization [J]","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111882_b0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality [J]","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat Rev Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724007927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724007927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:09:40Z","timestamp":1747415380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724007927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":60,"alternative-id":["S0168822724007927"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111882","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoglycemic drugs, circulating inflammatory proteins, and gallbladder diseases: A mediation mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111882"}}